N-containing heteroaryl derivatives as JAK3 kinase inhibitors

Details for Australian Patent Application No. 2010311378 (hide)

Owner Palau Pharma, S.A.

Inventors Almansa Rosales, Carmen; Salas Solana, Jorge; Soliva Soliva, Robert; Rodriguez Escrich, Sergio; Sicre Gonzalez, Maria Cristina

Agent Spruson & Ferguson

Pub. Number AU-A-2010311378

PCT Pub. Number WO2011/051452

Priority 61/291,051 30.12.09 US; 09382233.6 29.10.09 EP; 61/329,927 30.04.10 US

Filing date 29 October 2010

Wipo publication date 5 May 2011

International Classifications

C07D 519/04 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/52 (2006.01)

A61K 31/522 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/051452 Priority application(s): WO2011/051452

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010311379-Subsea pumping system

2010311376-Cardiac-specific nucleic acid regulatory elements and methods and use thereof